Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Archer

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Genes & Cancer|December 31, 2011
Role of sp transcription factors in the regulation of cancer cell metabolismMichael C Archer
Toxicology Letters|August 28, 2004
Creatine: a safety concernMichael C Archer
Nutrition (Burbank, Los Angeles County, Calif.)|August 25, 2004
The use of creatine to enhance athletic performanceMichael C Archer
International Journal of Cancer|July 22, 2009
Sp1 coordinately regulates de novo lipogenesis and proliferation in cancer cellsSuying Lu, Michael C Archer
Experimental Biology and Medicine (Maywood, N.J.)|April 28, 2007
Celecoxib decreases fatty acid synthase expression via down-regulation of c-Jun N-terminal kinase-1Suying Lu, Michael C Archer
Molecular Carcinogenesis|March 6, 2003
Insulin-like growth factor binding protein-1 over-expression in transgenic mice inhibits hepatic preneoplasiaSuying Lu, Michael C Archer
Carcinogenesis|September 11, 2004
Fatty acid synthase is a potential molecular target for the chemoprevention of breast cancerSuying Lu, Michael C Archer
International Journal of Cancer|December 4, 2009
Ezetimibe reverses the inhibitory effects of dietary cholesterol on mammary tumorigenesis in ratsErin McNamara, Michael C Archer
Biochemical and Biophysical Research Communications|March 17, 2006
Farnesol induces thyroid hormone receptor (THR) beta1 but inhibits THR-mediated signaling in MCF-7 human breast cancer cellsRobin E Duncan, Michael C Archer
Lipids|May 30, 2008
Farnesol decreases serum triglycerides in rats: identification of mechanisms including up-regulation of PPARalpha and down-regulation of fatty acid synthase in hepatocytesRobin E Duncan, Michael C Archer
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Genes & Cancer|December 31, 2011
Role of sp transcription factors in the regulation of cancer cell metabolismMichael C Archer
Toxicology Letters|August 28, 2004
Creatine: a safety concernMichael C Archer
Nutrition (Burbank, Los Angeles County, Calif.)|August 25, 2004
The use of creatine to enhance athletic performanceMichael C Archer
International Journal of Cancer|July 22, 2009
Sp1 coordinately regulates de novo lipogenesis and proliferation in cancer cellsSuying Lu, Michael C Archer
Experimental Biology and Medicine (Maywood, N.J.)|April 28, 2007
Celecoxib decreases fatty acid synthase expression via down-regulation of c-Jun N-terminal kinase-1Suying Lu, Michael C Archer
Molecular Carcinogenesis|March 6, 2003
Insulin-like growth factor binding protein-1 over-expression in transgenic mice inhibits hepatic preneoplasiaSuying Lu, Michael C Archer
Carcinogenesis|September 11, 2004
Fatty acid synthase is a potential molecular target for the chemoprevention of breast cancerSuying Lu, Michael C Archer
International Journal of Cancer|December 4, 2009
Ezetimibe reverses the inhibitory effects of dietary cholesterol on mammary tumorigenesis in ratsErin McNamara, Michael C Archer
Biochemical and Biophysical Research Communications|March 17, 2006
Farnesol induces thyroid hormone receptor (THR) beta1 but inhibits THR-mediated signaling in MCF-7 human breast cancer cellsRobin E Duncan, Michael C Archer
Lipids|May 30, 2008
Farnesol decreases serum triglycerides in rats: identification of mechanisms including up-regulation of PPARalpha and down-regulation of fatty acid synthase in hepatocytesRobin E Duncan, Michael C Archer
Pageof 5